SCHEMBL5729626

SCHEMBL5729626

CNCCC(c1ccc(F)cc1)n1cc(C)c2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 19/20 0.49
SLC6A4 P31645 17/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5732848 1.00 SLC6A2 (0.49) SLC6A2SLC6A4
SCHEMBL2074800 0.90 SLC6A2 (0.59) SLC6A2SLC6A4
SCHEMBL5728672 0.87 SLC6A2 (0.65) SLC6A2SLC6A4
SCHEMBL2074806 0.77 SLC6A2 (0.80) SLC6A2SLC6A4
SCHEMBL4076989 0.76 SLC6A2 (0.82) SLC6A2SLC6A4
SCHEMBL4077261 0.76 SLC6A2 (0.82) SLC6A2SLC6A4
SCHEMBL2074246 0.76 SLC6A2 (0.54) SLC6A2SLC6A4
SCHEMBL2073862 0.75 SLC6A2 (0.58) SLC6A2SLC6A4
Hydrochloric Acid SCHEMBL4079676 0.75 SLC6A2 (0.80) SLC6A2SLC6A4
SCHEMBL2074273 0.75 SLC6A4 (0.53) SLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1732887-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) Wyeth (US) 2006-12-20 EP claimed
WO-2005097744-A1 1-(1H-INDOL-1-YL)-3-(4-METHYLPIPERAZIN-1-YL)-1-PHENYL PROPAN-2-OL DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS OF THE NOREPINEPHRINE (NE) AND THE SEROTONINE (5-HT) ACTIVITY AND THE MONOAMINE REUPTAKE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS (VMS) WYETH (US) 2005-10-20 WO claimed